Streetbeat News

Price Targets

VRDN

Credit Suisse analyst Tiago Fauth assumes Viridian Therapeutics (NASDAQ:VRDN) with an Outperform rating and announces a price target of $51.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:22 am

VTYX

Credit Suisse analyst Tiago Fauth assumes Ventyx Biosciences (NASDAQ:VTYX) with an Outperform rating and announces a price target of $63.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:21 am

BMRN

Credit Suisse analyst Tiago Fauth assumes Biomarin Pharmaceutical (NASDAQ:BMRN) with an Outperform rating and announces a price target of $120.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:20 am

OVID

JonesTrading analyst Sean Kim initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announces a price target of $6.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:19 am

HD

Telsey Advisory Group analyst Joseph Feldman maintains an Outperform rating on Home Depot (NYSE:HD) and keeps the $315 price target.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 9:18 am

EYPT

JonesTrading analyst Sean Kim initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy rating and announces a price target of $26.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:13 am

WLK

Citigroup analyst Patrick Cunningham initiates coverage on Westlake (NYSE: WLK) with a Neutral rating and announces a price target of $114.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:12 am

SHW

Citigroup analyst Patrick Cunningham initiates coverage on Sherwin-Williams (NYSE:SHW) with a Buy rating and announces a price target of $283.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:10 am

PPG

Citigroup analyst Patrick Cunningham initiates coverage on PPG Industries (NYSE:PPG) with a Buy rating and announces a price target of $161.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:10 am

LIN

Citigroup analyst Patrick Cunningham initiates coverage on Linde (NYSE:LIN) with a Buy rating and announces a price target of $430.

Portfolio Pulse from richadhand@benzinga.com

June 14, 2023 | 9:07 am